- 1501. developmental psychology
- [branch of psychology concerned with the emotional, attitudinal, social, and intellectual changes in an individual between birth and death. ( CSP )] (UMLS (CSP) C0681955) =Biomedical Occupation or Discipline =psychology;
=child developmental psychology;
language development;
self concept;
socialization;
animal developmental psychology;
psychological aspect of aging | - 1551. Dexamethasone/Fludarabine/Mitoxantrone
- (UMLS (NCI) C0393032) =Therapeutic or Preventive Procedure
|
- 1502. Developmental speech or language disorder
- [ ] (UMLS (ICD9CM) C0154632) =Mental or Behavioral Dysfunction
| - 1552. Dexamethasone/Fludarabine/Pixantrone/Rituximab
- (UMLS (NCI) C1327857) =Therapeutic or Preventive Procedure
|
- 1503. Developmental Stage
- [A general term that usually refers to named landmark events during development of an organism. ( NCI )] (UMLS (NCI) C0870411) =Temporal Concept ;
| - 1553. Dexamethasone/Granisetron
- (UMLS (NCI) C0678002) =Therapeutic or Preventive Procedure
|
- 1504. developmentally disabled
- [ ] (UMLS (CSP) C0682150) =Patient or Disabled Group
| - 1554. Dexamethasone/Idarubicin
- (UMLS (NCI) C0935662) =Therapeutic or Preventive Procedure
|
- 1505. Developmentally-Regulated EPH-Related Tyrosine Kinase
- [Eph-related receptor tyrosine kinase B2; may have a role in neurogenesis (Proteome Summary, from LocusLink) ( NCI )] (UMLS (NCI) C0109317) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 1555. Dexamethasone/Idarubicin/Ifosfamide/Methotrexate/Thioguanine/Vincristine
- (UMLS (NCI) C0281687) =Therapeutic or Preventive Procedure
|
- 1506. DEVIATED NASAL SEPTUM
- (UMLS (ICD9CM) C0549397) =Anatomical Abnormality ;
| - 1556. Dexamethasone/Idarubicin/Imatinib Mesylate/Pegaspargase/Vincristine
- (UMLS (NCI) C1327814) =Therapeutic or Preventive Procedure ;
|
- 1507. Deviation
- [An alteration or difference from a norm or standard. ( NCI )] (UMLS (NCI) C0205419) =Qualitative Concept
| - 1557. Dexamethasone/Idarubicin/Pegaspargase/Vincristine
- (UMLS (NCI) C1327817) =Therapeutic or Preventive Procedure ;
|
- 1508. device
- [An object contrived for a specific purpose. ( NCI )] (UMLS (HL7) C0699733) =Manufactured Object =manufactured material;
=imaging modality;
certificate representation;
| - 1558. Dexamethasone/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine
- (UMLS (NCI) C1134462) =Therapeutic or Preventive Procedure
|
- 1509. Device
- (UMLS (HL7) C1547019) =Quantitative Concept =Kind of quantity;
| - 1559. Dexamethasone/Interferon Alfa
- (UMLS (NCI) C0338184) =Therapeutic or Preventive Procedure ;
|
- 1510. device
- [Something used in delivering the service without being substantially affected by the service (i.e. durable or inert with respect to that particular service). Examples are: monitoring equipment, tools, but also access/drainage lines, prostheses, pace maker, etc. ( HL7V3.0 )] (UMLS (HL7) C1550509) =Idea or Concept =direct target;
=reusable device;
non-reuseable device;
| - 1560. Dexamethasone/Isotretinoin
- (UMLS (NCI) C0935885) =Therapeutic or Preventive Procedure
|
- 1511. Device embedded in vessel or plaque
- [Device and/or fragments of device are embedded in patient's vessel and/or plaque. ( NCI )] (UMLS (NCI) C0854677) Medical Device Embedded In Vessel Or Plaque;
Plaque or vessel, device embedded in;
Vessel Or Plaque, Device Embedded In =Finding ;
| - 1561. Dexamethasone/Melphalan
- (UMLS (NCI) C0338234) =Therapeutic or Preventive Procedure
|
- 1512. Device evaluation
- (UMLS (HL7) C1546924) =Temporal Concept =Report timing;
| - 1562. Dexamethasone/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C0281126) =Therapeutic or Preventive Procedure
|
- 1513. Device Generic Type
- [Includes the set of codes used to identify a device that may be referred to in an ICSR report. Example code set reference is the FDA Center for Devices and Radiological Health product code list. Example product codes include: FOZ = Catheter, Intravascular, Therapeutic, short-term less than 30 days, MOP = Rotator, Prosthetic Heart Valve. ( HL7V3.0 )] (UMLS (HL7) C1699509) =Intellectual Product =EntityCode;
| - 1563. Dexamethasone/Mercaptopurine/Methotrexate/Vincristine
- (UMLS (NCI) C0281127) =Therapeutic or Preventive Procedure
|
- 1514. Device Plate
- [A sheet of metal or wood or glass or plastic. ( NCI )] (UMLS (NCI) C1139930) Plate =Medical Device ;
| - 1564. Dexamethasone/Mercaptopurine/Vincristine
- (UMLS (NCI) C0281217) =Therapeutic or Preventive Procedure ;
|
- 1515. Device Probe
- [An orthopedic manual surgical instrument is a nonpowered hand-held device intended for medical purposes to manipulate tissue, or for use with other devices in orthopedic surgery. This generic type of device includes the cerclage applier, awl, bender, drill brace, broach, burr, corkscrew, countersink, pin crimper, wire cutter, prosthesis driver, extractor, file, fork, needle holder, impactor, bending or contouring instrument, compression instrument, passer, socket positioner, probe, femoral neck punch, socket pusher, reamer, rongeur, scissors, screwdriver, bone skid, staple driver, bone screw starter, surgical stripper, tamp, bone tap, trephine, wire twister, and wrench. ( SPN )] (UMLS (NCI) C0182400) =Medical Device
| - 1565. Dexamethasone/Methotrexate
- (UMLS (NCI) C0796531) DM/MTX =Therapeutic or Preventive Procedure ;
|
- 1516. Device Scale
- (UMLS (NCI) C0175659) =Medical Device ;
| - 1566. Dexamethasone/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C0392950) =Therapeutic or Preventive Procedure
|
- 1517. Device Type
- [Generic category of medical device within the device classification established by FDA. It is used as part of regulatory product submission standard. ( NCI )] (UMLS (NCI) C0449497) =Qualitative Concept
| - 1567. Dexamethasone/Methotrexate/Procarbazine/Teniposide
- (UMLS (NCI) C0279211) =Therapeutic or Preventive Procedure
|
- 1518. Device Water Purification System
- (UMLS (NCI) C0184397) =Medical Device
| - 1568. Dexamethasone/Methotrexate/Procarbazine/Vincristine
- (UMLS (NCI) C0281652) =Therapeutic or Preventive Procedure ;
|
- 1519. DeviceAlertLevel
- [Domain values for the Device.Alert_levelCode ( HL7V3.0 )] (UMLS (HL7) C1553805) =Intellectual Product =CodeSystem;
=Normal;
Serious;
Critical;
Warning | - 1569. Dexamethasone/Methotrexate/Thioguanine
- (UMLS (NCI) C0278918) =Therapeutic or Preventive Procedure
|
- 1520. DeviceManufacturerEvaluationInterpretation
- [A code set that includes codes that are used to characterize the outcome of the device evaluation process. The code defines the manufacturer's conclusions following the evaluation. Examples include: inadequate alarms, device maintenance contributed to event, device failed just prior to use, user error caused event ( HL7V3.0 )] (UMLS (HL7) C1699004) =Finding =Individual Case Safety Report Value Domains;
| - 1570. Dexamethasone/Methotrexate/Thioguanine/Vincristine
- (UMLS (NCI) C0796378) DM/MTX/TG/VCR =Therapeutic or Preventive Procedure ;
|
- 1521. DeviceManufacturerEvaluationMethod
- [Code assigned to indicate a relevant fact within the context of the evaluation of a reported product. There are a number of concept types including the status of the evaluation, the type of evaluation findings, and the type of activity carried out as part of the evaluation process. Examples include: Actual device involved in incident was evaluated, electrical tests performed, visual examination. ( HL7V3.0 )] (UMLS (HL7) C1696159) =Finding =Individual Case Safety Report Value Domains;
| - 1571. Dexamethasone/Methotrexate/Thiotepa/Vincristine
- (UMLS (NCI) C0281370) =Therapeutic or Preventive Procedure
|
- 1522. DeviceManufacturerEvaluationResult
- [Code assigned to indicate an outcome of the manufacturer's investigation of a product for which a defect has been reported. Examples include:.component/subassembly failure: air cleaner, computer-, imaging system-, microprocessor-controlled device problem: cache memory, design — not fail safe. ( HL7V3.0 )] (UMLS (HL7) C1699514) =Finding =Individual Case Safety Report Value Domains;
| - 1572. Dexamethasone/Methotrexate/Vincristine
- (UMLS (NCI) C0879378) =Therapeutic or Preventive Procedure
|
- 1523. DeviceOperatorType
- [Indicates the type of person that is responsible for operating the device related to the incident reported in ICSR. Examples include: Physician, Nurse, Medical Technician, Respiratory Technician. ( HL7V3.0 )] (UMLS (HL7) C1698459) =Intellectual Product ;
=RoleCode;
| - 1573. Dexamethasone/Methotrexate/Zidovudine
- (UMLS (NCI) C0279010) =Therapeutic or Preventive Procedure ;
|
- 1524. Devils Claw
- [An herb obtained from the plant Harpagophytum procumbens. Devil's claw has been used as a tonic, as a hypoglycemic, to cleanse the lymph system, and in the treatment of arthritis, rheumatism, and skin cancer. This agent may have anti-inflammatory and analgesic properties, possibly due to the presence of antioxidants, phenols, tannins, triterpenoids and volatile oils. (NCI04) ( NCI )] (UMLS (NCI) C0771537) DEVILS CLAW PREPARATION;
Devil's claw preparation;
Devils Foot =Organic Chemical; Pharmacologic Substance =Unclassified Ingredients;
Unclassified Ingredient Preparations =DEVILS CLAW CAP/TAB;
| - 1574. Dexamethasone/Metoclopramide
- (UMLS (NCI) C0678001) =Therapeutic or Preventive Procedure
|
- 1525. DEX/MORPH
- (UMLS (NCI) C0796475) Dextromethorphan/Morphine =Therapeutic or Preventive Procedure
| - 1575. Dexamethasone/Metoclopramide/Midazolam
- (UMLS (NCI) C0280664) =Therapeutic or Preventive Procedure
|
- 1526. DEXA
- [A technique for scanning bone and measuring bone mineral density (BMD). A DXA scanner produces 2 X-ray beams, each with different energy levels. One beam is high energy while the other is low energy. The amount of x-rays that pass through the bone is measured for each beam. This will vary depending on the thickness of the bone. Based on the difference between the 2 beams, the bone density can be measured. ( NCI )] (UMLS (NCI) C1510486) Dual Energy X-ray Absorptometry;
Dual X-Ray Absorptiometry;
Dual X-ray Absorptometry;
DXA =Diagnostic Procedure ;
| - 1576. Dexamethasone/Oblimersen
- (UMLS (NCI) C1134606) =Therapeutic or Preventive Procedure
|
- 1527. Dexamethasone acetate
- [The acetate salt form of Dexamethasone, a synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04) ( NCI )] (UMLS (NCI) C0057598) =Steroid; Pharmacologic Substance ;
=(11Beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione;
=DEXAMETHASONE ACETATE MISC. POWDER (GM);
DEXAMETHASONE ACETATE 8 MG/ML;
DEXAMETHASONE ACETATE 16 MG/ML | - 1577. Dexamethasone/Oblimersen/Thalidomide
- (UMLS (NCI) C1327807) =Therapeutic or Preventive Procedure ;
|
- 1528. dexamethasone suppression test
- [injection of dexamethasone causes serum cortisol to fall; this can be correlated with behavioral measures of depression, but the test is not reliable enough for diagnostic use. ( CSP )] (UMLS (CSP) C0430115) =Laboratory Procedure =Administration of psychologic test;
| - 1578. Dexamethasone/Ondansetron
- (UMLS (NCI) C0935854) =Therapeutic or Preventive Procedure
|
- 1529. Dexamethasone/Dexniguldipine/Doxorubicin/Prednisone/Vincristine
- (UMLS (NCI) C0281631) =Therapeutic or Preventive Procedure
| - 1579. Dexamethasone/Pegaspargase
- (UMLS (NCI) C0935861) =Therapeutic or Preventive Procedure ;
|
- 1530. Dexamethasone/Dexniguldipine/Doxorubicin/Vincristine
- (UMLS (NCI) C0281632) =Therapeutic or Preventive Procedure
| - 1580. Dexamethasone/Pegaspargase/Vincristine
- (UMLS (NCI) C0338244) =Therapeutic or Preventive Procedure
|
- 1531. Dexamethasone/Doxorubicin
- (UMLS (NCI) C1134562) =Therapeutic or Preventive Procedure ;
| - 1581. Dexamethasone/Phenylbutyrate/Sargramostim
- (UMLS (NCI) C0935673) =Therapeutic or Preventive Procedure
|
- 1532. Dexamethasone/Doxorubicin/Interferon Alfa/Vincristine
- (UMLS (NCI) C0338098) =Therapeutic or Preventive Procedure ;
| - 1582. Dexamethasone/Rituximab
- (UMLS (NCI) C0796452) DM/MOAB IDEC-C2B8;
=Therapeutic or Preventive Procedure |
- 1533. Dexamethasone/Doxorubicin/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C0281125) =Therapeutic or Preventive Procedure
| - 1583. Dexamethasone/SU5416
- (UMLS (NCI) C0879617) =Therapeutic or Preventive Procedure
|
- 1534. Dexamethasone/Doxorubicin/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C0281121) =Therapeutic or Preventive Procedure
| - 1584. Dexamethasone/Thalidomide
- (UMLS (NCI) C1134614) =Therapeutic or Preventive Procedure ;
|
- 1535. Dexamethasone/Doxorubicin/Pegaspargase/Vincristine
- (UMLS (NCI) C0338243) =Therapeutic or Preventive Procedure
| - 1585. Dexamethasone/Vincristine
- (UMLS (NCI) C0281561) =Therapeutic or Preventive Procedure ;
|
- 1536. Dexamethasone/Doxorubicin/Prednisone/Quinine/Vincristine
- (UMLS (NCI) C0281414) =Therapeutic or Preventive Procedure
| - 1586. Dexasone
- (UMLS (NCI) C0701253) =Steroid; Pharmacologic Substance
|
- 1537. Dexamethasone/Doxorubicin/Prednisone/Vincristine
- (UMLS (NCI) C0281415) =Therapeutic or Preventive Procedure
| - 1587. DEXBROMPHENIRAMINE
- [An alkylamine derivative with anticholinergic and sedative properties. Dexbrompheniramine is a histamine H1-receptor antagonist that competes with histamine for the H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels and respiratory tract. The antagonistic action of this agent blocks the activities of endogenous histamine, which subsequently leads to temporary relief from the negative histamine-mediated symptoms of allergic reaction such as bronchoconstriction, vasodilation, increased capillary permeability and spasmodic contractions of gastrointestinal smooth muscle. ( NCI )] (UMLS (NCI) C0057605) =Organic Chemical; Pharmacologic Substance ;
=BROMPHENIRAMINE;
[AH400] ANTIHISTAMINES, ALKYLAMINE =Dexbrompheniramine Maleate;
DEXBROMPHENIRAMINE 3 MG;
|
- 1538. Dexamethasone/Doxorubicin/PSC 833/Vincristine
- (UMLS (NCI) C0392978) =Therapeutic or Preventive Procedure ;
| - 1588. Dexbrompheniramine Maleate
- [The maleate salt form of dexbrompheniramine, an alkylamine derivative with anticholinergic and sedative properties. Dexbrompheniramine is a histamine H1-receptor antagonist that competes with histamine for the H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels and respiratory tract. The antagonistic action of this agent blocks the activities of endogenous histamine, which subsequently leads to temporary relief from the negative histamine-mediated symptoms of allergic reaction such as bronchoconstriction, vasodilation, increased capillary permeability and spasmodic contractions of gastrointestinal smooth muscle. ( NCI )] (UMLS (NCI) C0113291) =Organic Chemical; Pharmacologic Substance =DEXBROMPHENIRAMINE;
=DEXBROMPHENIRAMINE MALEATE 2 MG;
DEXBROMPHENIRAMINE MALEATE 6 MG;
|
- 1539. Dexamethasone/Doxorubicin/Quinine/Verapamil/Vincristine
- (UMLS (NCI) C0280852) =Therapeutic or Preventive Procedure
| - 1589. DEXCHLORPHENIRAMINE
- [An alkylamine, and first-generation histamine antagonist with anti-allergic activity. Dexchlorpheniramine competitively blocks H1 receptors, thereby preventing the actions of histamine on bronchial smooth muscle, capillaries and gastrointestinal (GI) smooth muscle. The antagonistic action of this agent blocks the activities of endogenous histamine, thereby preventing histamine-induced bronchoconstriction, vasodilation, increased capillary permeability, and GI smooth muscle spasms. ( NCI )] (UMLS (NCI) C0057606) =Organic Chemical; Pharmacologic Substance ;
=chlorphenamine;
[AH400] ANTIHISTAMINES, ALKYLAMINE =(+)-2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate(1:1);
|
- 1540. Dexamethasone/Doxorubicin/Thalidomide
- (UMLS (NCI) C0935753) =Therapeutic or Preventive Procedure
| - 1590. dexedrine
- [ ] (UMLS (CSP) C0591355) =Organic Chemical; Pharmacologic Substance ;
|
- 1541. Dexamethasone/Doxorubicin/Thalidomide/Vincristine
- (UMLS (NCI) C1327876) =Therapeutic or Preventive Procedure ;
| - 1591. Dexmethylphenidate
- [The d-threo-enantiomer of methylphenidate, a central nervous system stimulant, appearing to block the reuptake of norepinephrine and dopamine into the presynaptic neuron, increasing their availability in the extracellular space. The mechanism of action in Attention Deficit Hyperactivity Disorder is unknown. (NCI) ( NCI )] (UMLS (NCI) C1169997) DEXMETHYLPHENIDATE PREPARATION =Organic Chemical; Pharmacologic Substance ;
=[CN802] AMPHETAMINE-LIKE STIMULANTS;
Unclassified Ingredients =DEXMETHYLPHENIDATE 2.5 MG;
DEXMETHYLPHENIDATE 5 MG;
DEXMETHYLPHENIDATE 10 MG;
|
- 1542. Dexamethasone/Doxorubicin/Verapamil/Vincristine
- (UMLS (NCI) C0280698) =Therapeutic or Preventive Procedure
| - 1592. Dexniguldipine
- [Dexniguldipine is the (+)-enantiomer of the dihydropyridine derivate niguldipine. Dexniguldipine showed a binding affinity to the P-glycoprotein and therefore it is to be assumed to block the P-glycoprotein pumping mechanism and to modulate multidrug resistance. (NCI) ( NCI )] (UMLS (NCI) C0208704) =Organic Chemical; Pharmacologic Substance ;
|
- 1543. Dexamethasone/Doxorubicin/Vincristine
- (UMLS (NCI) C0077973) =Therapeutic or Preventive Procedure ;
| - 1593. Dexoxadrol
- (UMLS (NCI) C0057609) =Organic Chemical; Pharmacologic Substance ;
|
- 1544. Dexamethasone/Epoetin Alfa
- (UMLS (NCI) C1327965) =Therapeutic or Preventive Procedure ;
| - 1594. dexpropranolol
- [ ] (UMLS (CSP) C0011792) =Organic Chemical; Pharmacologic Substance ;
|
- 1545. Dexamethasone/Etoposide/Ifosfamide
- (UMLS (NCI) C0879566) =Therapeutic or Preventive Procedure
| - 1595. Dexrazoxane Hydrochloride
- [The hydrochloride salt of a bisdioxopiperazine with cardioprotective and antineoplastic activities. After hydrolysis to an active form that is similar to ethylenediaminetetraacetic acid (EDTA), dexrazoxane chelates iron, thereby preventing the metal-catalyzed formation of reactive oxygen radicals produced by anthracycline antibiotics such as doxorubicin. This agent also inhibits the catalytic activity of topoisomerase II, resulting in cell growth inhibition. ( NCI )] (UMLS (NCI) C0982118) DEXRAZOXANE HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =(+)-(S)-4,4'-(1-Methyl-1,2-ethanediyl)di(2,6-piperazinedione);
=DEXRAZOXANE HYDROCHLORIDE 250 MG;
DEXRAZOXANE HYDROCHLORIDE 500 MG;
|
- 1546. Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C0281684) =Therapeutic or Preventive Procedure
| - 1596. Dexrazoxane/Doxorubicin/Ifosfamide
- (UMLS (NCI) C0796700) =Therapeutic or Preventive Procedure ;
|
- 1547. Dexamethasone/Etoposide/Ifosfamide/Pegaspargase/Vincristine
- (UMLS (NCI) C0392949) =Therapeutic or Preventive Procedure
| - 1597. Dextran Sulfate
- [Long-chain polymer of glucose containing 17-20% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4-POSITIVE T-LYMPHOCYTES. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications. ( MSH )] (UMLS (NCI) C0079224) =Carbohydrate; Pharmacologic Substance ;
|
- 1548. Dexamethasone/Floxuridine
- (UMLS (NCI) C0935752) =Therapeutic or Preventive Procedure
| - 1598. Dextran Sulfate Sodium
- [The sodium salt of sulfuric acid esters of glucose polymers. Dextran is produced by the action of the bacterium Leuconostoc mesenteroides and of other microorganisms on sucrose. This agent possesses strong hydrophilic properties and binds to various membranes, particularly those with a positive charge. (NCI04) ( NCI )] (UMLS (NCI) C0079225) =Carbohydrate; Pharmacologic Substance ;
|
- 1549. Dexamethasone/Floxuridine/Leucovorin Calcium/SCH-58500
- (UMLS (NCI) C0879305) =Therapeutic or Preventive Procedure
| - 1599. Dextroamphetamine Saccharate
- [The saccharate salt form of the dextro-isomer of amphetamine, a synthetic substance related to natural sympathomimetic amines, with CNS stimulating properties. Dextroamphetamine saccharate acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from its storage sites in nerve terminals in the brain, and inhibits their uptake within the mesocorticolimbic system, a major component of the brain reward system, thereby resulting in measurable behavioral changes such as euphoria. As a CNS stimulant, this agent may increase blood pressure and reduce appetite. Similar to other amphetamines, dextroamphetamine has a high potential for abuse, dependence, and addiction if used in large doses over extended periods of time. ( NCI )] (UMLS (NCI) C0724568) DEXTROAMPHETAMINE SACCHARATE PREPARATION;
=Organic Chemical; Pharmacologic Substance ;
=Dextroamphetamine;
=DEXTROAMPHETAMINE SACCHARATE 5 MG;
DEXTROAMPHETAMINE SACCHARATE 7.5 MG;
DEXTROAMPHETAMINE SACCHARATE 1.25 MG;
|
- 1550. Dexamethasone/Floxuridine/Mitomycin
- (UMLS (NCI) C0281389) =Therapeutic or Preventive Procedure ;
| - 1600. Dextroamphetamine-Amphetamine
- [A combination of two synthetic agents with central nervous system stimulant activity. Both agents are non-catecholamine, sympathomimetic agents that elevate blood pressure and cause bronchodilation. These agents are commonly abused psychostimulant drugs that induce psychologic dependence manifested by elevated mood, increased wakefulness, concentration, physical performance and a feeling of well-being. Tolerance to various effects develops unequally, so that tachycardia and enhanced alertness diminish while psychotoxic effects (hallucinations and delusions) may occur. (NCI04) ( NCI )] (UMLS (NCI) C0795571) =Organic Chemical; Pharmacologic Substance
|
home
